4.8 Article

Long noncoding RNA MALAT1 suppresses breast cancer metastasis

期刊

NATURE GENETICS
卷 50, 期 12, 页码 1705-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41588-018-0252-3

关键词

-

资金

  1. US National Institutes of Health (NIH) [R01CA166051, R01CA181029]
  2. Cancer Prevention and Research Institute of Texas (CPRIT) [RP150319]
  3. Stand Up To Cancer Innovative Research Grant [403235]
  4. NIH [R01CA164346, R01CA200703, R01CA175486, U24CA209851, R01CA181196, R01CA190370]
  5. CPRIT [RP140402]
  6. National Breast Cancer Foundation Inc.
  7. University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund
  8. CPRIT grant [RR140033]

向作者/读者索取更多资源

MALAT1 has previously been described as a metastasis-promoting long noncoding RNA (lncRNA). We show here, however, that targeted inactivation of the Malat1 gene in a transgenic mouse model of breast cancer, without altering the expression of its adjacent genes, promotes lung metastasis, and that this phenotype can be reversed by genetic add-back of Malat1. Similarly, knockout of MALAT1 in human breast cancer cells induces their metastatic ability, which is reversed by re-expression of Malat1. Conversely, overexpression of Malat1 suppresses breast cancer metastasis in transgenic, xenograft, and syngeneic models. Mechanistically, the MALAT1 lncRNA binds and inactivates the prometastatic transcription factor TEAD, preventing TEAD from associating with its co-activator YAP and target gene promoters. Moreover, MALAT1 levels inversely correlate with breast cancer progression and metastatic ability. These findings demonstrate that MALAT1 is a metastasis-suppressing lncRNA rather than a metastasis promoter in breast cancer, calling for rectification of the model for this highly abundant and conserved lncRNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据